
Metabolic treatment of cancer and other disorders
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 51 | Founded | a year ago | Last Issue | 5 days ago |
| Active | |||||

Metformin exerts multiple anticancer effects, mainly by reprogramming tumor and host metabolism and converging on mTOR and related growth/survival pathways. Numerous trials have shown that metformin, routinely used to treat diabetes, inhibi...
Subscribe now
Cancer progression is not simply a problem of uncontrolled cell growth. It is also a failure of immune surveillance. In a healthy host, abnormal cells are detected and eliminated by natural killer cells, cytotoxic CD8+ T cell...
Subscribe now
Peri-operative medications that reduce metastatic risk should be regarded as standard of care. With a simple, low-cost intervention, we can prevent avoidable deaths. Choosing not to offer this evidence-based treatment is, in...
Subscribe now
The recent two-part series on fatty acid oxidation in cancer generated considerable confusion and many questions. Dr. Thomas Seyfried reached out to me specifically to help clarify this issue. The observation that some cancer...
Subscribe now
This post steps away from my usual focus on cancer and metabolic disease and instead shares a deeply personal story: how I was pushed out of clinical medicine. COVID forced me to confront just how profoundly—and, at times, de...
Subscribers, engagement, traffic and sponsorship for Paul Marik.
| Subscribers | Engagement | 88 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Where Paul Marik ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 82 | Monthly Search Traffic | Top Keywords |
|---|
How this newsletter ranks in the official Substack charts.
| #101 | |
| #22 |
The writers behind this newsletter.
The treatment of Cancer and Metabolic diseases using diet, repurposed pharmaceuticals, and targeted nutraceuticals.
You can find recent issues that have been published by Paul Marik on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Paul Marik, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Paul Marik as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Paul Marik using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Paul Marik. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.